PK Consultancy provides clinical pharmacology, pharmacokinetic, and PK/PD modeling and simulation expertise. We will work in an integrated manner with your team.

Company Mission:

Scientific excellence and skilled technical capabilities, with a focus on technical expertise being current and attention to detail.
Provide high quality and consistent contracting services
Provide clinical pharmacology services to all clients in need in a timely manner
Further advance drug development

Capabilities:

Clinical and non-clinical NCA – Pharmacokinetic analysis plan (PKAP), PK 
                                                   analysis, TLG generation, report writing

Compartmental and population PK and PKPD – MAP, Analysis dataset generation, analysis, progress development meetings, and report

Graphical data analysis – can be used during clinical and non-clinical drug development in order to better understand data and drive program decision making

Prediction of first in human PK using allometric scaling

Study types:

FIH dose prediction
Dose escalation (with rapid turnaround)
Single Ascending Dose (SAD)
Multiple Ascending Doses (MAD)
Food Effect (FE)
Bioavailability/Bioequivalence (BA/BE)
Drug-Drug Interaction (DDI)
Special Population (hepatic and renal impairment)
Phase 3 studies
Post-marketing support





Patel Kwan Consultancy LLC

Org chart

Teams

Offices

Patel Kwan Consultancy LLC

Org chart

Teams

Offices

Related companies